Remote Monitoring and Social Intervention for High Blood Pressure
(E3 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This study aims to decrease the racial gap in high blood pressure in African American and Latinx patients in Rush University Medical Center clinics.
Who Is on the Research Team?
David A Ansell, MD, MPH
Principal Investigator
Rush University Medical Center
Laura J Zimmermann, MD
Principal Investigator
Rush University Medical Center
Are You a Good Fit for This Trial?
This trial is for African American and Latinx individuals with Stage II high blood pressure (140/90 or higher) who are patients at eligible Rush University Medical Center clinics. Participants must have access to a phone or device with video capabilities.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Enrollment and Initial Intervention
Participants are enrolled and introduced to the program, including verbal consent and initial screenings for social determinants of health and medication adherence.
Remote Monitoring and Intervention
Participants engage in remote blood pressure monitoring and receive weekly virtual visits from community health workers, with additional interventions from nurses and pharmacists as needed.
Follow-up
Participants are monitored for sustained improvement in blood pressure and adherence to interventions, with follow-up assessments at 3-6 months.
What Are the Treatments Tested in This Trial?
Interventions
- E3 Remote Monitoring and Social Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor
Novartis Pharmaceuticals
Industry Sponsor
Dr. Vas Narasimhan
Novartis Pharmaceuticals
Chief Executive Officer since 2018
MD from Harvard Medical School
Dr. Shreeram Aradhye
Novartis Pharmaceuticals
Chief Medical Officer since 2021
MD